BioMarin Pharmaceutical Inc. buy Guggenheim
Start price
13.09.23
/
50%
€85.26
Target price
13.09.24
€102.48
Performance (%)
-5.14%
Price
27.08.24
€80.88
Summary
This prediction is currently active. With a performance of -5.14%, the BUY prediction by Guggenheim is trending in the wrong direction. This prediction currently runs until 13.09.24. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -4.102% | -4.102% |
| iShares Core DAX® | 1.743% | 1.903% |
| iShares Nasdaq 100 | -2.088% | -0.640% |
| iShares Nikkei 225® | 1.306% | 4.161% |
| iShares S&P 500 | -0.093% | 0.169% |
Comments by Guggenheim for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $110.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Guggenheim for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€94.17
28.02.23
28.02.23
€117.80
28.02.24
28.02.24
-13.41%
29.02.24
29.02.24
